Sort
30,917 grants matching “tumor microenvironment”
Targeting the Vascular System
$272,833Tracy T Batchelor · Massachusetts General Hospital · P50 · FY2016 · CA
Collaborative Research: Design and mechanistic studies on microenvironment-sensitive polymeric nanoparticles for simultaneous contents release and ultrasound imaging
$272,799Sanku Mallik · South Dakota State University · · FY2025 · MPS
Vascular Maintenance and Brain Tumor Refractory
$272,786P Charles Lin · Vanderbilt University · R01 · FY2006 · NS
Early Phase Clinical Trials in Imaging and Image-Guided Interventions
$272,770Aerang Kim · Children'S Research Institute · R01 · FY2015 · CA
Transcriptional Role of BRCA1 in Breast Cancer
$272,694Wen-Hwa Lee · University Of California-Irvine · R01 · FY2010 · CA
Regulation of Fibronectin Matrix Assembly by uPAR
$272,648Paula J Mc Keown-Longo · Albany Medical College · R01 · FY2012 · CA
Regulation of Fibronectin Matrix Assembly by uPAR
$272,648Paula J Mc Keown-Longo · Albany Medical College · R01 · FY2011 · CA
Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma Cells
$272,628Shigeki Miyamoto · University Of Wisconsin-Madison · R01 · FY2014 · CA
Biomarkers of the Proinflammatory Response and Elements of Immune Suppression
$272,582Ahmad A. Tarhini · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · CA
Vitamin D in Prostate Cancer: Tumor Vasculature Effects
$272,579Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
Targeting immunosuppression blockade to T cells for cancer immunotherapy
$272,535Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2014 · CA
Developing novel CAR T cell designs using combinatorial antigen detection
$272,518Greg Maness Allen · University Of California, San Francisco · K08 · FY2025 · CA
Targeted immunotherapy for relapsed/refractory Hodgkin lymphoma
$272,491Robert Wi Chen · Beckman Research Institute/City Of Hope · P50 · FY2022 · CA
Regulation of the Tumor Microenvironment by KSHV
$272,446Christopher H Parsons · Lsu Health Sciences Center · R01 · FY2013 · CA
Design, Synthesis, and Evaluation of ant-Glioblastoma Agents
$272,445Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · GM
Project 04 - Develop a portfolio of agents for switching that match biology of residual tumor burden
$272,435Douglas Yee · University Of California, San Francisco · P01 · FY2021 · CA
Project 04 - Develop a portfolio of agents for switching that match biology of residual tumor burden
$272,435Douglas Yee · University Of California, San Francisco · P01 · FY2020 · CA
Analysis of the Signaling and Mechanical Cues Promoting Invasion in Melanoma
$272,428Andre Levchenko · Yale University · U01 · FY2014 · CA
Molecular Pathology and Genomics Core
$272,421Jon C Aster · Dana-Farber Cancer Inst · P01 · FY2023 · CA
New 3D tumor models to rapidly test drugs for brain cancer therapy
$272,389Miqin Zhang · University Of Washington · R01 · FY2016 · CA
Project 4: Off-the-shelf engineered cord blood-derived natural killer cells for the treatment acute lymphoblastic leukemia
$272,373Katy Rezvani · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Project 3 - Modulation of host cell biology by KSHV
$272,323Blossom A Damania · Univ Of North Carolina Chapel Hill · P01 · FY2019 · CA
Regulation of Adhesion and Proteolysis in Ovarian Cancer
$272,318Ernst Lengyel · University Of Chicago · R01 · FY2015 · CA
Regulation of Adhesion and Proteolysis in Ovarian Cancer
$272,318Ernst Lengyel · University Of Chicago · R01 · FY2016 · CA
P-4: Targeting activation of NFkB pathways in MM
$272,300Peter Leif Bergsagel · Dana-Farber Cancer Inst · P50 · FY2011 · CA